| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 08/17/2005 | EP1562935A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 08/17/2005 | EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
| 08/17/2005 | CN1656091A Tetrahydropyran derivatives |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/11/2005 | WO2005046588A3 Compounds, compositions, and methods |
| 08/11/2005 | US20050176748 Vinorelbine derivatives |
| 08/11/2005 | US20050176737 Mitotic kinesin inhibitors |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders |
| 08/11/2005 | US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
| 08/11/2005 | US20050175984 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 08/10/2005 | EP1560827A1 Anti-infective agents |
| 08/10/2005 | EP1560821A2 Antibacterial agents |
| 08/10/2005 | EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 08/10/2005 | EP1560584A2 Fab i inhibitors |
| 08/10/2005 | EP1560488A2 Antibacterial agents |
| 08/10/2005 | EP0888301B1 Mcbi analogs of cc-1065 and the duocarmycins |
| 08/10/2005 | CN1653072A Broad -spectrum cephem compounds |
| 08/10/2005 | CN1653070A Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 08/10/2005 | CN1653050A Opioid and opioid-like compounds and uses thereof |
| 08/10/2005 | CN1214009C antibacterial composition |
| 08/09/2005 | US6927226 Antidepressant azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene |
| 08/09/2005 | US6927220 Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 08/04/2005 | WO2005071096A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample |
| 08/04/2005 | WO2005070941A1 Rifamycin imino derivatives effective against drug-resistant microbes |
| 08/04/2005 | WO2005070934A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors |
| 08/04/2005 | WO2005070133A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
| 08/04/2005 | WO2004091485A3 Aminoquinoline compounds |
| 08/04/2005 | US20050171191 citrus-based furocoumarins; for dietary supplements or medicinal foods; bioavailability |
| 08/04/2005 | US20050171144 Imidazo[1,2-a] pyridine anxiolytics |
| 08/04/2005 | US20050171128 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2005 | US20050171122 Mitotic kinesin inhibitors |
| 08/04/2005 | US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | CA2553242A1 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
| 08/04/2005 | CA2553232A1 Substituted heterocyclic compounds and methods of use |
| 08/03/2005 | EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias |
| 08/03/2005 | EP1558616A2 Meso-substituted porphyrins |
| 08/03/2005 | EP1558615A1 Purine compounds and use thereof as cannabinoid receptor ligands |
| 08/03/2005 | EP1558586A2 Inhibitors of akt activity |
| 08/03/2005 | EP1558252A2 Substituted furo 2,3-b] pyridine derivatives |
| 08/03/2005 | CN1649883A Bicyclic 6-alkylidene-penems as lactamases inhibitors |
| 08/03/2005 | CN1649882A Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors |
| 08/03/2005 | CN1649881A Process for preparing 6-alkylidene penem derivatives |
| 08/03/2005 | CN1649877A Process for the preparation of clopidogrel |
| 08/03/2005 | CN1649874A Antiparasitic artemisinin derivatives (endoperoxides) |
| 08/03/2005 | CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives |
| 08/03/2005 | CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1648641A Fluorescent chemical sensor using silicon heterocyclic penta-diene as fluorescient material and its use |
| 08/03/2005 | CN1212839C Use of substituted pyrazoles in preparing medicine for treating allergies |
| 08/02/2005 | US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents |
| 07/28/2005 | WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | US20050165227 Antiproliferative agents; gene overexpression |
| 07/28/2005 | US20050165047 alpha 7 nicotinic acetylcholine receptor agonist; dissolving N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide to an alcohol, adding fumaric acid, precipitating salt out of the solution; neurodegenerative and psychological disorders |
| 07/28/2005 | DE10357571A1 Multifunktionelle 3,4-Alkylendioxythiophen-Derivate und diese enthaltende elektrisch leitfähige Polymere Multifunctional 3,4-alkylenedioxythiophene derivatives and containing electrically conductive polymers |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646156A Strategy for retroviral immunotherapy |
| 07/26/2005 | US6921765 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 07/26/2005 | CA2324848C Method of making camptothecin and camptothecin analogs |
| 07/21/2005 | WO2005066176A1 Pyrrolotriazine compounds as kinase inhibitors |
| 07/21/2005 | WO2004055004A8 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/21/2005 | US20050159426 Novartis drug called Imatinib, 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, methanosulfonate; synergistic mixture with a second antineoplastic agent |
| 07/21/2005 | US20050159422 Inhibitors of akt activity |
| 07/21/2005 | US20050159411 Bactericides for infrections in man |
| 07/21/2005 | US20050159401 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 07/21/2005 | US20050159388 Non-nucleotide compositions and method for inhibiting platelet aggregation |
| 07/20/2005 | EP1555267A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES |
| 07/20/2005 | EP1305305A4 Hyperpolarizable organic chromophores |
| 07/20/2005 | CN1642959A Novel dithiolopyrrolones with therapeutic activity |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/19/2005 | US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors |
| 07/19/2005 | US6919327 Texaphyrin coordination compounds and uses thereof |
| 07/14/2005 | WO2005063744A2 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005062882A2 Rifamycin analogs and uses thereof |
| 07/14/2005 | WO2005023816A3 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compouds and uses thereof |
| 07/14/2005 | US20050153950 Broad -spectrum cephem compounds |
| 07/14/2005 | CA2550729A1 Rifamycin analogs and uses thereof |
| 07/14/2005 | CA2549606A1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
| 07/13/2005 | EP1551841A1 Pyrazolopyrimidines as kinase inhibitors |
| 07/13/2005 | EP1551840A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/13/2005 | EP1551825A1 Novel direct black dyes with three heteroaromatic rings |
| 07/13/2005 | EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/13/2005 | EP1551412A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/13/2005 | EP1551389A2 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents |
| 07/13/2005 | CN1639165A Purine derivatives as kinase inhibitors |
| 07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
| 07/13/2005 | CN1637002A Cephalosporin ester compound resisting beta-lactamase and its salt |
| 07/13/2005 | CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 07/12/2005 | US6916818 Nitrogen compounds such as 1-(1-Naphthalenesulfonyl)-3-(octa-hydro-4-quinolizinyl)-1H-5-azaindole, used as serotonin receptor antagonists for prophylaxis of psychological disorders |
| 07/07/2005 | WO2005061657A1 Single-layer organic el device |